AMAT
49
-3
LEG
29
4
CTAS
56
-5
GT
46
3
AIZ
71
-2
AEE
61
-2
AKAM
56
-2
SHW
71
-2
HRB
70
-3
XOM
48
3
WEC
46
-4
MNST
52
2
HBI
59
-2
M
14
2
AVY
54
-14
SWN
70
3
HON
55
-4
ES
55
-5
NUE
50
3
MPC
44
3
AMAT
49
-3
LEG
29
4
CTAS
56
-5
GT
46
3
AIZ
71
-2
AEE
61
-2
AKAM
56
-2
SHW
71
-2
HRB
70
-3
XOM
48
3
WEC
46
-4
MNST
52
2
HBI
59
-2
M
14
2
AVY
54
-14
SWN
70
3
HON
55
-4
ES
55
-5
NUE
50
3
MPC
44
3
Financhill
Back

Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
32

AUTL
Autolus Therapeutics PLC

Last Price:
3.95
Seasonality Move:
-0.26%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Autolus Therapeutics PLC Price Quote

$3.95
+0.09 (+2.33%)
(Updated: September 19, 2024 at 12:30 PM ET)

Autolus Therapeutics PLC Key Stats

Sell
32
Autolus Therapeutics PLC (AUTL) is a Sell
Day range:
$3.83 - $4.01
52-week range:
$2.01 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.95%
Volume:
996.7K
Avg. volume:
668.3K
1-year change:
37.37%
Market cap:
$1B
Revenue:
$1.7M
EPS:
$-1.17

How Much Does Autolus Therapeutics PLC Make?

Data Unavailable

Is Autolus Therapeutics PLC Growing As A Company?

Data Unavailable

Autolus Therapeutics PLC Stock Price Performance

What Is Autolus Therapeutics PLC 52-Week High & Low?

Autolus Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Autolus Therapeutics PLC?

Is Autolus Therapeutics PLC Cash Flow Positive?

  • What Is AUTL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$156.6M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $559.4M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.3M

Autolus Therapeutics PLC Return On Invested Capital

Data Unavailable

Autolus Therapeutics PLC Earnings Date & Stock Price

Autolus Therapeutics PLC Competitors

Autolus Therapeutics PLC Dividend Yield

Autolus Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.22
Upside from Last Price: 164.82%

Major Shareholders

  • How many AUTL shares are owned by institutional investors?
    201.3M AUTL shares are owned by institutional investors
  • How many AUTL shares are owned by insiders?
    0 AUTL shares are owned by insiders